Octapharma USA, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13.7M | 1,888 | 77.8% |
| Honoraria | $1.2M | 434 | 6.6% |
| Grant | $885,287 | 10 | 5.0% |
| Travel and Lodging | $651,481 | 1,239 | 3.7% |
| Food and Beverage | $622,832 | 19,300 | 3.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $437,220 | 15 | 2.5% |
| Consulting Fee | $140,954 | 154 | 0.8% |
| Education | $3,150 | 34 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Von Willebrand Factor in Pregnancy (VIP) Study | $2.0M | 0 | 2 |
| GAM10-10 | $1.2M | 3 | 67 |
| NGAM-13 | $1.2M | 8 | 106 |
| INdividualized ITI based on fviii ATE protection by vwf INITIATE | $1.1M | 0 | 1 |
| GAM5-28 | $1.0M | 2 | 331 |
| LEX-211 | $1.0M | 4 | 30 |
| GAM10-08 | $880,249 | 8 | 204 |
| SCGAM-06 | $683,480 | 7 | 178 |
| LEX-209 | $452,610 | 11 | 196 |
| NORM-01 | $383,258 | 1 | 70 |
| NGAM-12 | $348,562 | 4 | 117 |
| LEX-210 | $329,999 | 1 | 35 |
| Von Willebrand Factor in Pregnancy | $329,662 | 0 | 8 |
| SCGAM-03 | $319,159 | 4 | 51 |
| NGAM-10 | $241,150 | 3 | 77 |
| SCGAM-01 | $193,594 | 0 | 32 |
| LAS-215 | $176,936 | 3 | 31 |
| LAS-213 | $161,157 | 5 | 45 |
| CUTAQUIG REGISTRY | $151,582 | 0 | 3 |
| Gena-21b | $120,638 | 0 | 45 |
| Cutaquig Registry | $119,129 | 0 | 1 |
| Gena-05 | $118,264 | 0 | 29 |
| PPH STUDY | $114,955 | 0 | 3 |
| ATN-106 | $105,448 | 1 | 9 |
| GENA-21b | $102,902 | 0 | 16 |
| LAS-212 | $86,005 | 4 | 24 |
| PANS STUDY | $81,078 | 0 | 2 |
| NGAM-11 | $67,223 | 7 | 18 |
| OCTAPLAS IIS STUDY | $62,165 | 0 | 4 |
| GENA-05 | $52,387 | 5 | 30 |
Payments by Medical Specialty
Top Paid Doctors — Page 6
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Dr. Bruce Spiess, M.d, M.D | Anesthesiology | Gainesville, FL | $5,100 | $0 |
| Peter Donofrio, Md, MD | Neurology | Nashville, TN | $5,096 | $0 |
| Dr. Philip Spinella, Md, MD | Pediatrics | Saint Louis, MO | $5,075 | $0 |
| Marcelo Matiello, Md, Msc, MD, MSC | Neurology | New Haven, CT | $5,068 | $0 |
| Dr. Ralph Shapiro, M.d, M.D | Allergy & Immunology | Plymouth, MN | $5,040 | $0 |
| Dr. Wellington Tichenor, M.d, M.D | Allergy | New York, NY | $5,015 | $0 |
| Dr. David Ward, M.d, M.D | Internal Medicine | San Diego, CA | $5,000 | $0 |
| Elena Schiopu, Md, MD | Internal Medicine | Ann Arbor, MI | $4,937 | $0 |
| Truman Milling, Md, MD | Emergency Medical Services | Austin, TX | $4,931 | $0 |
| Alexander Butwick, Md, MD | Anesthesiology | San Francisco, CA | $4,880 | $0 |
| Karen Zimowski, Md, MD | Pediatrics | Atlanta, GA | $4,877 | $0 |
| Richard Morse, Md, MD | Neurodevelopmental Disabilities | Lebanon, NH | $4,825 | $0 |
| Kathirvel Subramaniam | Anesthesiology | Pittsburgh, PA | $4,812 | $0 |
| Dr. Noah Kolb, M.d, M.D | Neurology | Burlington, VT | $4,804 | $0 |
| Dr. Matthew Neal, Md, MD | Surgical Critical Care | Pittsburgh, PA | $4,779 | $0 |
| Dr. Melanie Elchico, M.d, M.D | Diagnostic Radiology | San Diego, CA | $4,703 | $0 |
| Gregory Nuttall, M.d, M.D | Anesthesiology | Rochester, MN | $4,685 | $0 |
| Jonathan Bernstein, M.d, M.D | Pediatric Hematology-Oncology | Hershey, PA | $4,649 | $0 |
| Vanessa Salinas-Luna, Md, MD | Pediatrics | Orange, CA | $4,588 | $0 |
| Wei Ding, Md, MD | Medical Oncology | Stanford, CA | $4,555 | $0 |
| Dr. Andrej Spec, Md, MD | Infectious Disease | Saint Louis, MO | $4,486 | $0 |
| Mindy Simpson, M.d, M.D | Pediatrics | Chicago, IL | $4,477 | $0 |
| Vinod Balasa, M.d, M.D | Pediatric Hematology-Oncology | Madera, CA | $4,425 | $0 |
| Meera Chitlur, Md, MD | Pediatrics | Detroit, MI | $4,321 | $0 |
| Dr. Susan Goobie, Md, MD | Anesthesiology | Boston, MA | $4,110 | $0 |
Top Products
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) $2.9M
- OCTAGAM IMMUNE GLOBULIN (HUMAN) $2.4M
Associated Products (14)
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) $2.9M
- OCTAGAM IMMUNE GLOBULIN (HUMAN) $2.8M
- PANZYGA $2.5M
- WILATE $2.0M
- CUTAQUIG $1.6M
- OCTAGAM $1.4M
- NUWIQ $1.1M
- OCTAPLAS $560,635
- FIBRYGA $418,333
- OCTAPLEX $400,900
- OCTANORM $341,872
- CUTAQUIQ $82,876
- BALFAXAR $49,885
- IVIG $29,114
Payment Categories
- Food & Beverage $622,832
- Consulting $140,954
- Travel & Lodging $651,481
- Research $13.7M
About Octapharma USA, Inc.
Octapharma USA, Inc. has made $17.6M in payments to 7,638 healthcare providers, recorded across 23,074 transactions in the CMS Open Payments database. In 2024, the company paid $1.8M. The top product by payment volume is WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) ($2.9M).
Payments were distributed across 166 medical specialties. The top specialty by payment amount is Pediatric Hematology-Oncology ($603,018 to 125 doctors).
Payment categories include: Food & Beverage ($622,832), Consulting ($140,954), Research ($13.7M), Travel & Lodging ($651,481).
Octapharma USA, Inc. is associated with 14 products in the CMS Open Payments database, including WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN), OCTAGAM IMMUNE GLOBULIN (HUMAN), and PANZYGA.